Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kassim Javaid has joined an interdisciplinary team embarking on a new 3-year project to advise on the best practice of Artificial Intelligence (AI) in healthcare to ensure it benefits everyone in the UK and Japan.

Horizontal portrait of Kassim Javid

Professor Jane Kaye, Director of The Centre for Health, Law, and Emerging Technologies (HeLEX) at the University of Oxford, in collaboration with Professor Beverley Yamamoto of Osaka University in Japan has convened the interdisciplinary team which includes researchers from social science, medicine, life science, and ethical and legal backgrounds.

The research will adopt a mixed-methods approach and aims to investigate effective strategies to support a platform for stakeholder engagement and involvement in the development and implementation of AI technologies in healthcare settings. Alongside the empirical research, the project will recruit a patient and public involvement panel to contribute to the project activities.

"With AI increasingly being used within the NHS and in future potential applications, it is critical that patients and the public are involved as we develop the governance and privacy issues around this new technology," said Kassim. "As a clinician who has implemented AI in the NHS setting, I will be contributing to the clinical aspects as well as supporting the patient co-development of the outputs."

The research will focus on:

  • What are the current and anticipated uses of AI technologies in treatment, diagnostic decision-making and precision medicine;
  • Understanding the issues that stakeholders perceive will influence the adoption and implementation of AI in healthcare;
  • Identifying the types of engagement mechanisms, safeguards and regulatory controls they would like to see in place; and
  • How to development a platform for engagement that can address issues of trust, responsibility, accountability and transparency, and influence normative practices in the implementation of AI technologies in healthcare.

The project is one of six which have been funded through UK Research and Innovation's (UKRI) Fund for International Collaboration (FIC) in a joint UK-Japan initiative. The Economic and Social Research Council (ESRC) and the Arts and Humanities Research Council (AHRC), both part of UKRI, contributed £2.4m via FIC, while the Japanese Science and Technology Agency (JST) contributed ¥180m.

 

 

Similar stories

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.

New research could improve quality of life for Psoriatic Arthritis patients

Professors Laura Coates and Dani Prieto-Alhambra will take major roles in a new European Commission project to develop innovative personalised treatment options for people affected by psoriatic arthritis.